InnovAge Holding Beheer

Beheer criteriumcontroles 1/4

De CEO InnovAge Holding is Patrick Blair, benoemd in Jan2022, heeft een ambtstermijn van 2.83 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 4.94M, bestaande uit 16.7% salaris en 83.3% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 1.17% van de aandelen van het bedrijf, ter waarde $ 7.42M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.5 jaar en 3.7 jaar.

Belangrijke informatie

Patrick Blair

Algemeen directeur

US$4.9m

Totale compensatie

Percentage CEO-salaris	16.7%
Dienstverband CEO	2.8yrs
Eigendom CEO	1.2%
Management gemiddelde ambtstermijn	1.5yrs
Gemiddelde ambtstermijn bestuur	3.7yrs

Recente managementupdates

Recent updates

Investors Aren't Entirely Convinced By InnovAge Holding Corp.'s (NASDAQ:INNV) Revenues

Nov 07

Is InnovAge Holding (NASDAQ:INNV) A Risky Investment?

Aug 20

InnovAge Holding Corp.'s (NASDAQ:INNV) Shares Leap 30% Yet They're Still Not Telling The Full Story

Jun 28

InnovAge Holding Corp.'s (NASDAQ:INNV) Intrinsic Value Is Potentially 73% Above Its Share Price

Aug 10

Cautious Investors Not Rewarding InnovAge Holding Corp.'s (NASDAQ:INNV) Performance Completely

Jun 08

InnovAge GAAP EPS of -$0.09 misses by $0.06, revenue of $172.86M misses by $1.11M

Sep 13

InnovAge names Richard Feifer as chief medical officer

Aug 17

InnovAge Holding (NASDAQ:INNV) Could Be Struggling To Allocate Capital

Jul 27

Earnings Miss: InnovAge Holding Corp. Missed EPS And Analysts Are Revising Their Forecasts

May 12

Here's What's Concerning About InnovAge Holding's (NASDAQ:INNV) Returns On Capital

Apr 14

Is There An Opportunity With InnovAge Holding Corp.'s (NASDAQ:INNV) 30% Undervaluation?

Mar 24

InnovAge Pursues Compliance As Precursor To Post-Pandemic Growth

Mar 19

InnovAge Holding's (NASDAQ:INNV) Robust Earnings Are Supported By Other Strong Factors

Nov 16

Are Investors Undervaluing InnovAge Holding Corp. (NASDAQ:INNV) By 48%?

Jul 28

Analyse CEO-vergoeding

Hoe is Patrick Blair's beloning veranderd ten opzichte van InnovAge Holding's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	-US$16m
Jun 30 2024	US$5m	US$826k	-US$21m
Mar 31 2024	n/a	n/a	-US$31m
Dec 31 2023	n/a	n/a	-US$32m
Sep 30 2023	n/a	n/a	-US$38m
Jun 30 2023	US$2m	US$750k	-US$41m
Mar 31 2023	n/a	n/a	-US$42m
Dec 31 2022	n/a	n/a	-US$38m
Sep 30 2022	n/a	n/a	-US$27m
Jun 30 2022	US$8m	US$438k	-US$7m

Compensatie versus markt: De totale vergoeding ($USD 4.94M ) Patrick } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 3.20M ).

Compensatie versus inkomsten: De vergoeding van Patrick is gestegen terwijl het bedrijf verliesgevend is.

CEO

Patrick Blair (53 yo)

2.8yrs

Tenure

US$4,940,894

Compensatie

Mr. Patrick Blair servesd as President of InnovAge Holding Corp. since December 1, 2021 and serves as CEO since January 01, 2022. He had been the Chief Marketing Officer and Senior Vice President of Commer...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Patrick Blair	Chief Executive Officer	2.8yrs	US$4.94m	1.17% $ 7.4m
Benjamin Adams	Chief Financial Officer	1.3yrs	US$2.51m	geen gegevens
Nicole D'Amato	Chief Legal Officer & Corporate Secretary	3.3yrs	US$1.61m	0.051% $ 322.3k
Edward Kennedy	Independent Director	no data	US$100.00k	0.017% $ 108.1k
Marilyn Tavenner	Independent Director	no data	US$120.00k	geen gegevens
Michael Scarbrough	President & COO	no data	geen gegevens	geen gegevens
Cara Babachicos	Chief Information Officer	1.7yrs	geen gegevens	geen gegevens
Ryan Kubota	Director of Investor Relations	no data	geen gegevens	geen gegevens
Olivia Patton	Chief Compliance Officer	no data	geen gegevens	geen gegevens
Matt Huray	Chief Strategy & Corporate Development Officer	1.2yrs	geen gegevens	geen gegevens
Rob Borella	Chief Sales & Marketing Officer	2.3yrs	geen gegevens	geen gegevens
Dustin Lee	Chief People Officer	less than a year	geen gegevens	geen gegevens

1.5yrs

Gemiddelde duur

60yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van INNV wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.5 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Edward Kennedy	Independent Director	3.7yrs	US$100.00k	0.017% $ 108.1k
Marilyn Tavenner	Independent Director	3.7yrs	US$120.00k	geen gegevens
Andrew Cavanna	Director	3.7yrs	geen gegevens	geen gegevens
James Carlson	Independent Non-Executive Chairman	2.4yrs	US$200.00k	0.031% $ 196.8k
Thomas Scully	Director	3.7yrs	geen gegevens	0.074% $ 470.0k
Richard Zoretic	Independent Director	3.7yrs	US$100.00k	geen gegevens
John Bush	Independent Director	3.7yrs	US$100.00k	geen gegevens
Teresa Sparks	Independent Director	1.3yrs	US$220.00k	0.013% $ 81.6k
Patricia Fontneau	Independent Director	1.7yrs	US$100.00k	0.011% $ 67.2k

3.7yrs

Gemiddelde duur

65yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van INNV wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.7 jaar).

InnovAge Holding Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

InnovAge Holding Corp. Announces Executive Changes

InnovAge Holding Corp., Annual General Meeting, Dec 05, 2024

InnovAge Holding Corp. Appoints John Koehn as Senior Vice President of External Affairs

InnovAge Holding Corp., Annual General Meeting, Dec 13, 2023

Innovage Holding Corp. Names Darlene Flaig as New Chief Nursing Officer

InnovAge Holding Corp. Announces the Appointment of Teresa Sparks to Its Board of Directors

Recent updates

Investors Aren't Entirely Convinced By InnovAge Holding Corp.'s (NASDAQ:INNV) Revenues

First quarter 2025 earnings: EPS misses analyst expectations

InnovAge Holding Corp. Announces Executive Changes

InnovAge Holding Corp. to Report Q1, 2025 Results on Nov 05, 2024

InnovAge Holding Corp., Annual General Meeting, Dec 05, 2024

Price target increased by 8.3% to US$6.50

Consensus EPS estimates fall from profit to US$0.022 loss

Full year 2024 earnings: EPS and revenues exceed analyst expectations

InnovAge Holding Corp. Provides Earnings Guidance for Full Fiscal Year 2025

InnovAge Holding Corp. to Report Q4, 2024 Results on Sep 10, 2024

Is InnovAge Holding (NASDAQ:INNV) A Risky Investment?

InnovAge Holding Corp.'s (NASDAQ:INNV) Shares Leap 30% Yet They're Still Not Telling The Full Story

InnovAge Holding Corp. (NasdaqGS:INNV) announces an Equity Buyback for $5 million worth of its shares.

New minor risk - Share price stability

InnovAge Holding Corp. Appoints John Koehn as Senior Vice President of External Affairs

Price target decreased by 12% to US$6.00

InnovAge Holding Corp. Reiterates Financial Guidance for the Full Fiscal Year 2024

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Sentiment Still Eluding InnovAge Holding Corp. (NASDAQ:INNV)

InnovAge Holding Corp. to Report Q3, 2024 Results on May 07, 2024

InnovAge Holding (NASDAQ:INNV) Has Debt But No Earnings; Should You Worry?

Price target decreased by 9.3% to US$6.50

Consensus EPS estimates fall by 18%

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

InnovAge Holding Corp. Provides Earnings Guidance for the Full Fiscal Year 2024

InnovAge Holding Corp. to Report Q2, 2024 Results on Feb 06, 2024

Market Still Lacking Some Conviction On InnovAge Holding Corp. (NASDAQ:INNV)

Consensus EPS estimates fall by 113%

Consensus EPS estimates fall by 127%, revenue upgraded

First quarter 2024 earnings: EPS misses analyst expectations

InnovAge Holding Corp., Annual General Meeting, Dec 13, 2023

InnovAge Holding Corp. to Report Q1, 2024 Results on Nov 07, 2023

Innovage Holding Corp. Names Darlene Flaig as New Chief Nursing Officer

Consensus EPS estimates fall by 60%

Price target decreased by 8.3% to US$7.33

InnovAge Holding Corp. Provides Full Fiscal Year 2024 Financial Guidance

Full year 2023 earnings: EPS misses analyst expectations

InnovAge Holding Corp. to Report Q4, 2023 Results on Sep 12, 2023

InnovAge Holding Corp. Announces the Appointment of Teresa Sparks to Its Board of Directors

InnovAge Holding Corp.'s (NASDAQ:INNV) Intrinsic Value Is Potentially 73% Above Its Share Price

Now 21% undervalued

InnovAge Holding Corp. Announces CFO Changes

Now 20% undervalued after recent price drop

InnovAge Holding Corp.(NasdaqGS:INNV) dropped from Russell Small Cap Comp Value Index

Cautious Investors Not Rewarding InnovAge Holding Corp.'s (NASDAQ:INNV) Performance Completely

Now 24% undervalued after recent price drop

Third quarter 2023 earnings: EPS misses analyst expectations

Consensus EPS estimates upgraded to US$0.24 loss

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

InnovAge Holding Corp. to Report Q2, 2023 Results on Feb 07, 2023

Price target increased to US$7.00

High number of new and inexperienced directors

InnovAge Holding Corp., Annual General Meeting, Dec 13, 2022

InnovAge Holding Corp. to Report Q1, 2023 Results on Nov 08, 2022

InnovAge Holding Corp. Not Provides Earnings Guidance for the Fiscal Year 2023

Investor sentiment improved over the past week

InnovAge GAAP EPS of -$0.09 misses by $0.06, revenue of $172.86M misses by $1.11M

InnovAge Holding Corp. to Report Q4, 2022 Results on Sep 13, 2022

InnovAge Holding Corp. Appoints Kathy Andreasen as Chief People Officer

InnovAge Holding Corp. Names Richard Feifer as Chief Medical Officer

InnovAge names Richard Feifer as chief medical officer

InnovAge Holding (NASDAQ:INNV) Could Be Struggling To Allocate Capital

InnovAge Appoints James Carlson to Its Board of Directors and as Non-Executive Chairman

Investor sentiment deteriorated over the past week

Consensus forecasts updated

Price target decreased to US$4.70

Earnings Miss: InnovAge Holding Corp. Missed EPS And Analysts Are Revising Their Forecasts

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent